8-KThe WireRoutine
Shareholder Vote
Filed May 31, 2024 · 2y ago · Accession 0001714899-24-000125
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Denali Therapeutics Inc.
- Ticker
- DNLI
- CIK
- 1714899
- Form type
- 8-K
- Filing date
- May 31, 2024
- Report date
- May 31, 2024
- Document
- dnli-20240531.htm
- Size
- 163 KB